These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 30820705)

  • 1. Comparison between clinical significance of serum CXCL-8 and classical tumor markers in oesophageal cancer (OC) patients.
    Łukaszewicz-Zając M; Pączek S; Muszyński P; Kozłowski M; Mroczko B
    Clin Exp Med; 2019 May; 19(2):191-199. PubMed ID: 30820705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CXCL-8 in Preoperative Colorectal Cancer Patients: Significance for Diagnosis and Cancer Progression.
    Pączek S; Łukaszewicz-Zając M; Gryko M; Mroczko P; Kulczyńska-Przybik A; Mroczko B
    Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32192002
    [No Abstract]   [Full Text] [Related]  

  • 3. Higher importance of interleukin 6 than classic tumor markers (carcinoembryonic antigen and squamous cell cancer antigen) in the diagnosis of esophageal cancer patients.
    Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Dis Esophagus; 2012 Apr; 25(3):242-9. PubMed ID: 21895853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of serum C-reactive protein (CRP) levels in the different histological subtypes of esophageal cancer (squamous cell carcinoma and adenocarcinoma of esophagus).
    Lukaszewicz-Zając M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Siewko M; Szmitkowski M
    J Clin Lab Anal; 2012 Feb; 26(2):73-81. PubMed ID: 22467322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer.
    Łukaszewicz-Zając M; Mroczko B; Kozłowski M; Szmitkowski M
    Dis Markers; 2016; 2016():7963895. PubMed ID: 27041792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum concentrations of receptor for interleukin 8 in patients with esophageal cancer.
    Łukaszewicz-Zając M; Kulczyńska-Przybik A; Muszyński P; Kozłowski M; Szmitkowski M; Mroczko B
    Pol Arch Med Wewn; 2016 Oct; 126(11):854-861. PubMed ID: 27906878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of CXCL-8/CXCR-2 network in esophageal squamous cell carcinoma.
    Ogura M; Takeuchi H; Kawakubo H; Nishi T; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Miyasho T; Yamada S; Kitagawa Y
    Surgery; 2013 Sep; 154(3):512-20. PubMed ID: 23972657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of serum macrophage-colony stimulating factor (M-CSF) in esophageal cancer patients and its comparison with classical tumor markers.
    Łukaszewicz-Zajac M; Mroczko B; Kozłowski M; Nikliński J; Laudański J; Szmitkowski M
    Clin Chem Lab Med; 2010 Oct; 48(10):1467-73. PubMed ID: 20604722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Significance of Serum Chemokines in Esophageal Cancer.
    Li Z; Qian J; Li J; Zhu C
    Med Sci Monit; 2019 Aug; 25():5850-5855. PubMed ID: 31385574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and adenocarcinoma of the oesophagus.
    Gockel I; Dirksen K; Messow CM; Junginger T
    World J Gastroenterol; 2006 Jun; 12(23):3746-50. PubMed ID: 16773693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis.
    Huang Z; Li Z; Chen X; Zhu X; Zhang J; Song Y; Cao Y; Lu P
    Biomed Res Int; 2022; 2022():1213968. PubMed ID: 36567905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The alcohol dehydrogenase isoenzyme (ADH IV) as a candidate tumour marker of esophageal cancer.
    Jelski W; Laniewska-Dunaj M; Niklinski J; Kozłowski M; Laudanski J; Szmitkowski M
    Acta Biochim Pol; 2013; 60(3):489-93. PubMed ID: 24051444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic tumor markers CA 19-9 and CEA.
    Litman-Zawadzka A; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B
    Pol Arch Intern Med; 2018 Sep; 128(9):524-531. PubMed ID: 30057378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Early Diagnostic Value of Serum Interleukin-8 in Esophagogastric Junction Adenocarcinoma.
    Li Z; Xu H; Yu J; Liu C; Zheng C; Zeng R; Xu L; Li E; Peng Y; Xu Y
    Cancer Control; 2021; 28():10732748211004883. PubMed ID: 33926265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CDC25B autoantibody predicts poor prognosis in patients with advanced esophageal squamous cell carcinoma.
    Dong J; Zeng BH; Xu LH; Wang JY; Li MZ; Zeng MS; Liu WL
    J Transl Med; 2010 Sep; 8():81. PubMed ID: 20813067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer.
    Lukaszewicz-Zając M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
    Clin Exp Med; 2011 Jun; 11(2):89-96. PubMed ID: 20938721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum miR-626 and miR-5100 are Promising Prognosis Predictors for Oral Squamous Cell Carcinoma.
    Shi J; Bao X; Liu Z; Zhang Z; Chen W; Xu Q
    Theranostics; 2019; 9(4):920-931. PubMed ID: 30867806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of M-CSF and VEGF in laboratory diagnostics and differentiation of selected histological types of cervical cancers.
    Sidorkiewicz I; Zbucka-Krętowska M; Zaręba K; Lubowicka E; Zajkowska M; Szmitkowski M; Gacuta E; Ławicki S
    BMC Cancer; 2019 Apr; 19(1):398. PubMed ID: 31035945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte growth factor promotes cancer cell migration and angiogenic factors expression: a prognostic marker of human esophageal squamous cell carcinomas.
    Ren Y; Cao B; Law S; Xie Y; Lee PY; Cheung L; Chen Y; Huang X; Chan HM; Zhao P; Luk J; Vande Woude G; Wong J
    Clin Cancer Res; 2005 Sep; 11(17):6190-7. PubMed ID: 16144920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of serum HGF and CK18 levels in patients with esophageal cancer.
    Kilic-Baygutalp N; Ozturk N; Orsal-Ibisoglu E; Gündogdu B; Ozgeris FB; Bakan N; Bakan E; Kilic AF
    Genet Mol Res; 2016 Aug; 15(3):. PubMed ID: 27706656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.